based on colour formation by the Trinder reaction.P This assay lacks the sensitivity necessary for application to dilute lipoprotein fractions. We have therefore developed a micromethod, capable of measuring sub-nanomolar quantities of TAG, based on the formation of a coloured formazan by reduction of 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride (INT) .4 Initially we tried to develop a two-stage assay in which free glycerol was allowed to react, then lipase added and the increment in glycerol measured. However, it was not possible to obtain complete reaction under these conditions. The method therefore involves separate estimations, one of free glycerol (without lipase) and one of total glycerol (with lipase present).
The final concentrations in the reagent mixture are as shown in Table 1 . The INT is made up as a 12mmol/L solution in distilled water and is added just before use, as the mixture turns pink on standing. We run the method onthe Instrumentation Laboratories Multistat III Microcentrifugal Analyzer (IL (UK) Ltd, Warrington, UK). The loader settings are the same for both free and total glycerol on plasma: sample volume 4 JLL with a 36 JLL wash; reagent volume 100JLL with a 10JLL wash. The reference cuvette contains water instead of sample. The assays are run with glycerol standards of 1 mmol/ Land 2 mmol/L. The wavelength is 500 nm and the run time is 10 min. The temperature is 30°C for free glycerol, but 37°C for total glycerol in order to avoid longer run times. (Free glycerol can also be measured at 37°C, but in practice the time taken for the Multistat to reach that temperature outweighs any shortening of run-time.) The TAG concentration is calculated from the difference between total and free glycerol. For lipoprotein fractions the sample volume can be increased to 30 JLL, with standards of 250 and 500 JLmol/L. Enzymatic methods for measurement of triacylglycerol (TAG) are based on hydrolysis of the TAG with a lipase, and measurement of the resulting glycerol. The need for the correction for free glycerol in the sample depends on the purposes of the measurement; this correction is usually about 10% of the total in plasma, but this proportion will vary if TAG is measured in, for instance, separated lipoprotein fractions. We have been investigating a particular case; that of measurement of TAG extraction across adipose tissue in vivo. l In the venous drainage from adipose tissue, the free glycerol concentration is typically 30--40% of the TAG, and accurate correction is necessary for measurement of the small arteriovenous differences observed for TAG. Methods for the measurement of TAG without interference by free glycerol have been described, were included in all runs and the coefficient of variation (CV) between runs was 2·2% for Precinorm (mean value 254 Jlmol/L; n = 59) and 2·4% for Precipath (mean value 902 Jlmol/L; n = 59). For lower concentrations, the withinrun CV was calculated from the differences between duplicates at various concentrations: it was 3·9% at a mean value of 22 Jlmol/L (n = 33), 5-4% at a mean value of 13Jlmol/L (n = 10) and 6·1% at a mean value of 8·5 Jlmol/ L (n = 4). (These CVs are all for final results after correction for free glycerol.) The formal limit of detection is thus well below 10Jlmol/L; in a sample volume of 30 JlL, this represents detection of less than 300pmol TAG. Analytical recovery is difficult to measure in a strict sense for TAG since a concentrated aqueous TAG solution cannot be prepared. It was tested by mixing different proportions (50:50,75:25 v/v) of 10 samples of plasma (with TAG concentrations from O'5 to 2 mmol/L) and an aqueous TAG standard (3-4mmol/L; Sigma Chemical Company, Poole, UK). The concentrations in the plasma samples and in the stan-dard were measured, and the (observed x 100) expected concentration in the mixtures calculated as a 'pseudo-recovery'. Mean values ± SD were 101·7 ± 1·9% and 102·6 ± 2,2%, respectively. (All values were corrected for free glycerol.)
